BMB-101

N/A

Report date: 2024/09/19 11:28:17
NME

Base Information

Drug NameBMB-101
Drug Alias NameBMB101BMB-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsBinge-Eating DisorderOpioid-Related DisordersPrader-Willi Syndrome +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBright Minds Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBright Minds Biosciences Inc
Inactive CompaniesN/A
Active IndicationsBinge-Eating DisorderOpioid-Related DisordersPrader-Willi Syndrome +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A